000 | 03542nam a22005895i 4500 | ||
---|---|---|---|
001 | 978-3-540-48264-2 | ||
003 | DE-He213 | ||
005 | 20161121230959.0 | ||
007 | cr nn 008mamaa | ||
008 | 100301s2007 gw | s |||| 0|eng d | ||
020 |
_a9783540482642 _9978-3-540-48264-2 |
||
024 | 7 |
_a10.1007/978-3-540-48264-2 _2doi |
|
050 | 4 | _aHD28-70 | |
072 | 7 |
_aKJMV6 _2bicssc |
|
072 | 7 |
_aPDG _2bicssc |
|
072 | 7 |
_aBUS087000 _2bisacsh |
|
082 | 0 | 4 |
_a658.514 _223 |
100 | 1 |
_aBaecker, Philipp N. _eauthor. |
|
245 | 1 | 0 |
_aReal Options and Intellectual Property _h[electronic resource] : _bCapital Budgeting Under Imperfect Patent Protection / _cby Philipp N. Baecker. |
264 | 1 |
_aBerlin, Heidelberg : _bSpringer Berlin Heidelberg, _c2007. |
|
300 |
_aX, 282 p. 47 illus. _bonline resource. |
||
336 |
_atext _btxt _2rdacontent |
||
337 |
_acomputer _bc _2rdamedia |
||
338 |
_aonline resource _bcr _2rdacarrier |
||
347 |
_atext file _bPDF _2rda |
||
490 | 1 |
_aLecture Notes in Economics and Mathematical Systems, _x0075-8442 ; _v587 |
|
505 | 0 | _aPatenting Under Uncertainty -- Patent Protection, the Firm, and the Economy -- Uncertainty, Irreversibility, and Flexibility -- Patent Protection in the Pharmaceutical Industry -- Exogenous Patent Risk -- and Related Work -- Patents as Investment Opportunities -- Patent Risk as Jumps in the Underlying Process -- From Business Shifts to Jump Processes -- Preliminary Conclusion -- Endogenous Patent Risk -- and Related Work -- Patent Risk as an Option to Litigate -- Preliminary Conclusion -- Conclusion. | |
520 | _aOver the last years, due to intensive competition in the knowledge economy, legal aspects surrounding intellectual property (IP) rights - including litigation and settlement - have continuously gained in importance. Correspondingly, professional IP management has become an indispensable element of successful value-based management (VBM) in research-intensive firms. With this text, the author proposes an integrated approach to patent risk and capital budgeting in pharmaceutical research and development (R and D), developing an option-based view (OBV) of imperfect patent protection, which draws upon contingent-claims analysis, stochastic game theory, as well as novel numerical methods. Bridging a widening gap between recent advances in the theory of financial analysis and current challenges faced by pharmaceutical companies, the text re-initiates a discussion about the contribution of quantitative frameworks to value-based R and D management. | ||
650 | 0 | _aBusiness. | |
650 | 0 | _aManagement. | |
650 | 0 | _aIndustrial management. | |
650 | 0 | _aOperations research. | |
650 | 0 | _aDecision making. | |
650 | 0 | _aFinance. | |
650 | 0 | _aEconomics, Mathematical. | |
650 | 0 | _aEconomic theory. | |
650 | 0 | _aMacroeconomics. | |
650 | 1 | 4 | _aBusiness and Management. |
650 | 2 | 4 | _aInnovation/Technology Management. |
650 | 2 | 4 | _aMacroeconomics/Monetary Economics//Financial Economics. |
650 | 2 | 4 | _aFinance, general. |
650 | 2 | 4 | _aEconomic Theory/Quantitative Economics/Mathematical Methods. |
650 | 2 | 4 | _aQuantitative Finance. |
650 | 2 | 4 | _aOperation Research/Decision Theory. |
710 | 2 | _aSpringerLink (Online service) | |
773 | 0 | _tSpringer eBooks | |
776 | 0 | 8 |
_iPrinted edition: _z9783540482635 |
830 | 0 |
_aLecture Notes in Economics and Mathematical Systems, _x0075-8442 ; _v587 |
|
856 | 4 | 0 | _uhttp://dx.doi.org/10.1007/978-3-540-48264-2 |
912 | _aZDB-2-SBE | ||
950 | _aBusiness and Economics (Springer-11643) | ||
999 |
_c506769 _d506769 |